Supported by world leading research organisations
Pebble brings together all the elements needed to finance early-stage companies
in the plant and microbial sector creating a safer, healthier,
sustainable and more profitable world
Pebble brings together all the elements needed to finance early-stage companies
in the plant and microbial sector creating a safer, healthier,
sustainable and more profitable world
PBL Technology invests in, protects and promotes emerging bioscience innovations from public research sources worldwide – turning ideas into patented, scientifically validated and licensable technologies. PBL Technology establishes intellectual property protection, guides development through the proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners.
PBL has invested over £12m in IP protection for public research innovations
PBL has provided services to over 80 different institutions in 14 countries in 5 continents
PBL has shared over £11m in revenues to source institutions
PBL has patented over 350 technologies, transferring over 180 to industry